Scientists pinpoint a new line of defence used by cancer cells

December 8, 2014
The image shows cancer cells where the number of chromosomes in each nucleus is not as it should be -- a condition known as "aneuploidy." The green spots show a marker for the chromosomes, and the red and blue fluorescent stains highlight two different parts of the cell's internal skeleton. Credit: Image courtesy of Dr Nicola Brownlow and Professor Peter Parker from the Cancer Research UK London Research Institute.

Cancer Research UK scientists have discovered a new line of defence used by cancer cells to evade cell death, according to research published in Nature Communications today.

The team identified a critical pathway of molecular signals which throw a lifeline to , enabling them to survive even though they contain vast DNA errors which would usually trigger .

The PKCƐ (Protein Kinase C epsilon), which is used by cancer cells but rarely by normal cells, could be important in targeting some cancer cells as they rely on this pathway to survive.

The pathway helps the cancer cells survive by allowing them to untangle and separate their DNA. Cancer cells rely on this signal pathway more than because their DNA is more jumbled and prone to becoming tangled.

Turning off the pathway can trigger cancer cells to self-destruct because the machinery used to untangle the DNA fails, meaning it is torn apart as the cell divides - ravaging and causing huge breaks in the code which lead to the cancer cells' demise.

Lead researcher Dr Nicola Brownlow, Cancer Research UK scientist at the Cancer Research UK London Research Institute, said: "Taking out this line of defence could be a powerful way to target the disease and re-programme cancer cells to self-destruct.

"The next step in our research is to understand which cancer types have this weak spot and to look for a marker that will allow us to test patients for cancers with this fault."

A cell's ability to divide in two is fundamental to life. These white blobs show DNA being separated as cells divide. But if mistakes are made, this can lead to genetic errors, and cancer. Credit: Cancer Research UK

Nell Barrie, Cancer Research UK's senior science information manager, said: "This research has uncovered an important weakness which we could use to tackle cancer. Newer, precise methods which target the dents in cancer's armoury provide fresh opportunities for better treatments to help more people survive the disease.

"There's still a lot of work to do before this research leads to a new cancer treatment, but it offers us a new strategy to beat the disease by helping us to understand what causes and drives cancer."

Explore further: Scientists trigger self-destruct switch in lung cancer cells

More information: Brownlow et al. Mitotic catenation is monitored and resolved by a PKCε-regulated pathway. Nature Communications. DOI: 10.1038/ncomm6685.

Related Stories

Scientists trigger self-destruct switch in lung cancer cells

October 31, 2014
Cancer Research UK scientists have found a drug combination that can trigger the self-destruct process in lung cancer cells - paving the way for new treatments, according to research that will be presented at the National ...

Scientists discover why bowel cancer sometimes outsmarts treatment

December 1, 2014
A new study that challenges the prevailing view of how bowel cancer develops in the large intestine is published today in Nature Medicine.

Possible breast cancer 'achilles heel' discovered

October 15, 2014
A leading team of Newcastle University scientists have found that 'turning off' two proteins reduces the ability of breast cancer cells to survive and grow.

Scientists discover new route to boost pancreatic cancer treatment

May 30, 2014
Cancer Research UK scientists have uncovered new insights into how a key pancreatic cancer drug – gemcitabine – is broken down in tumour cells, according to research* published in the British Journal of Cancer (BJC), ...

Scientists uncover vast numbers of DNA 'blind spots' that may hide cancer-causing mistakes

November 14, 2014
Cancer Research UK scientists have found more than 400 'blind spots' in DNA which could hide cancer-causing gene faults, according to research published today in Cancer Research.

Mesothelial cells promote ovarian cancer metastasis

September 9, 2014
Less than half of the women diagnosed with ovarian cancer will survive beyond 5 years. Ovarian cancer readily spreads to abdominal organs, which are covered by a layer of cells called the mesothelium. Ovarian cancer cells ...

Recommended for you

CAR-T immunotherapy may help blood cancer patients who don't respond to standard treatments

October 20, 2017
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis is one of the first centers nationwide to offer a new immunotherapy that targets certain blood cancers. Newly approved ...

Researchers pinpoint causes for spike in breast cancer genetic testing

October 20, 2017
A sharp rise in the number of women seeking BRCA genetic testing to evaluate their risk of developing breast cancer was driven by multiple factors, including celebrity endorsement, according to researchers at the University ...

Study shows how nerves drive prostate cancer

October 19, 2017
In a study in today's issue of Science, researchers at Albert Einstein College of Medicine, part of Montefiore Medicine, report that certain nerves sustain prostate cancer growth by triggering a switch that causes tumor vessels ...

Gene circuit switches on inside cancer cells, triggers immune attack

October 19, 2017
Researchers at MIT have developed a synthetic gene circuit that triggers the body's immune system to attack cancers when it detects signs of the disease.

One to 10 mutations are needed to drive cancer, scientists find

October 19, 2017
For the first time, scientists have provided unbiased estimates of the number of mutations needed for cancers to develop, in a study of more than 7,500 tumours across 29 cancer types. Researchers from the Wellcome Trust Sanger ...

Researchers target undruggable cancers

October 19, 2017
A new approach to targeting key cancer-linked proteins, thought to be 'undruggable," has been discovered through an alliance between industry and academia.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.